Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-11-21

Clinical Trial Update: Tegoprazan Plus Amoxicillin BID vs TID Regimens for H. Pylori Eradication(Frequency Adjusted Same-dose Therapy for H. Pylori) [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial compares tegoprazan plus amoxicillin given twice daily versus a thrice-daily regimen for Helicobacter pylori eradication; the study is …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • AMOXICILLIN (AMOXICILLIN)
  • Tegoprazan (tegoprazan)

Snippet

Sponsor: First People's Hospital of Hangzhou | Conditions: HELICOBACTER PYLORI INFECTIONS | Phase 4 | Status: NOT_YET_RECRUITING